High-Dose Itraconazole As a Noncastrating Therapy for a Patient With Biochemically Recurrent Prostate Cancer
Published in Clinical Genitourinary Cancer
Six-Month Progression-Free Survival as the Primary Endpoint to Evaluate the Activity of New Agents as Second-line Therap...
...Published in Clinical Genitourinary Cancer
ObjectiveSecond-line systemic therapy for advanced urothelial carcinoma (UC) has substantial unmet needs, and current agents show dismal activity. Second-line trials of metastatic UC have used response rate (RR) and median progression-free survival (PFS) as primary endpoints, which may not reflect durable benefits. A more robust endpoint to identif...
Durable Complete Remission From Castration-Resistant Prostate Cancer With Sipuleucel-T After Estrogen Withdrawal
Published in Clinical Genitourinary Cancer
Cisplatin-Ineligible and Chemotherapy-Ineligible Patients Should Be the Focus of New Drug Development in Patients With A...
Published in Clinical Genitourinary Cancer
Robot-Assisted Radical Nephroureterectomy for Upper Urinary Tract Urothelial Carcinoma: A Promising Alternative to Open ...
Published in Clinical Genitourinary Cancer
Re: Iodine-125 Seed Implantation and Deferred Transurethral Resection of the Prostate for Patients With Lower Urinary Tr...
Published in Clinical Genitourinary Cancer
Prostate Mucinous Carcinoma Treated With Definitive Radiotherapy and Hormonal Therapy: Case Report and Review of the Lit...
Published in Clinical Genitourinary Cancer
Computed Tomography Characteristics of Unresectable Primary Renal Cell Carcinoma Treated With Neoadjuvant Sunitinib
Published in Clinical Genitourinary Cancer
IntroductionIn patients with locally advanced and metastatic RCC, selection criteria for nephrectomy are imprecise. Neoadjuvant sunitinib might downsize unresectable tumors and enable nephrectomy. CT scans of unresectable primary RCCs before and after neoadjuvant sunitinib were retrospectively reviewed to identify radiographic features associated w...
Outcomes of Patients With Metastatic Renal Cell Carcinoma and End-Stage Renal Disease Receiving Dialysis and Targeted Th...
Published in Clinical Genitourinary Cancer
IntroductionLimited data are available regarding patients with renal cell carcinoma and ESRD treated with TTs. The objective of this study was to explore the tolerability and safety of TT in patients with mRCC and ESRD. Patients and MethodsWe retrospectively identified patients with mRCC and ESRD treated at the University of Texas M.D. Anderson Can...
Editorial Board
Published in Clinical Genitourinary Cancer
